S. 1038 118th Congress
Drug Price Transparency in Medicaid Act of 2023
Latest action, Mar 29, 2023: Read twice and referred to the Committee on Finance.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
3 cosponsors
Sponsored by Peter Welch (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
1 D · 2 R
- Democrat
- Republican
- Independent
Referred to: Senate: Finance Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
8 reports
8 reports
NATIONAL TAXPAYERS UNION
8 reports
AMERICAN MEDICAL ASSOCIATION
LOPER CONSULTING LLC
7 reports
7 reports
6 reports
6 reports
6 reports
3 reports
3 reports
2 reports
All 25 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| FOOD MARKETPLACE INC | 8 | $2.7M | Q1 2023 | Q3 2024 | yes | |
| KROGER CO | 8 | $3.1M | Q1 2023 | Q3 2024 | yes | |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 8 | $2.9M | Q1 2023 | Q3 2024 | yes | |
| NATIONAL TAXPAYERS UNION | 8 | $240K | Q1 2023 | Q3 2024 | yes | |
| AMERICAN MEDICAL ASSOCIATION | LOPER CONSULTING LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| INDEPENDENT PHARMACY COOPERATIVE | 7 | $340K | Q4 2023 | Q3 2024 | yes | |
| 340B HEALTH | 6 | $1.9M | Q4 2023 | Q3 2024 | yes | |
| AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) | 6 | $17.5M | Q4 2023 | Q3 2024 | yes | |
| HIGHMARK INC | 6 | $1.1M | Q4 2023 | Q3 2024 | yes | |
| NATIONWIDE CHILDREN'S HOSPITAL INC | 6 | $325K | Q4 2023 | Q3 2024 | yes | |
| PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION | 5 | $20.2M | Q1 2023 | Q1 2024 | yes | |
| NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 3 | $1.0M | Q4 2023 | Q3 2023 | yes | |
| NOVARTIS | 3 | $3.3M | Q4 2023 | Q3 2023 | yes | |
| TAKEDA PHARMACEUTICALS AMERICA INC | 3 | $3.1M | Q4 2023 | Q3 2023 | yes | |
| ALBERTSONS COMPANIES, INC. | 2 | $1.4M | Q4 2024 | Q3 2024 | yes | |
| AMERICAN PHARMACIES, INC. | ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) | 2 | $120K | Q1 2023 | Q4 2023 | yes |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | 2 | $3.3M | Q2 2023 | Q3 2023 | yes | |
| BLUE CROSS AND BLUE SHIELD OF FLORIDA INC | 2 | $360K | Q2 2023 | Q3 2023 | yes | |
| BLUE CROSS BLUE SHIELD OF MICHIGAN | 2 | $538K | Q2 2023 | Q3 2023 | yes | |
| GUIDEWELL MUTUAL HOLDING CORPORATION | 2 | $0 | Q2 2023 | Q3 2023 | yes | |
| HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY | 2 | $30K | Q4 2023 | Q3 2023 | yes | |
| NORIDIAN MUTUAL INSURANCE COMPANY | 2 | $0 | Q2 2023 | Q3 2023 | yes | |
| SECURITIES INDUSTRY AND FINANCIAL MARKETS ASSOCIATION | 2 | $2.9M | Q1 2023 | Q2 2023 | yes | |
| ASTRAZENECA PHARMACEUTICALS LP | 1 | $830K | Q2 2023 | Q2 2023 | yes | |
| HEALTH CARE SERVICE CORPORATION, A MUTUAL LEGAL RESERVE COMPANY (HCSC) | 1 | $830K | Q3 2023 | Q3 2023 | yes |